Abstract
Although the saphenous vein (SV) is a widely used conduit for coronary artery bypass graft surgery (CABG), lower long-term graft patency rates and worse clinical outcomes have been reported after CABG performed with SV grafts compared with CABG performed with internal thoracic artery (ITA) grafts. Of various efforts to overcome the limitations of SV that are resulting from structural and functional differences from arterial conduit, recent improvement in harvesting techniques including no-touch technique, surgical strategy of using the SV as part of a composite graft over an aortocoronary bypass graft, and external stenting of the SV will be discussed in this topic.
Similar content being viewed by others
References
Jones DS. CABG at 50 (or 107?) - The complex course of therapeutic innovation. N Engl J Med. 2017;376:1809–11.
Barboriak JJ, Pintar K, Korns ME. Atherosclerosis in aortocoronary vein grafts. Lancet. 1974;304:621–4.
Campeau L, Enjalbert M, Lespérance J, Vaislic C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation. 1983;68:II1–7.
Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. New Engl J Med. 1986;314:1–6.
Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med. 1996;334:216–9.
Roubos N, Rosenfeldt FL, Richards SM, Conyers RA, Davis BB. Improved preservation of saphenous vein grafts by the use of glyceryl trinitrate-verapamil solution during harvesting. Circulation. 1995;92:II-31–6.
Ratliff NB, Myles JL. Rapidly progressive atherosclerosis in aortocoronary saphenous vein grafts. Possible immune-mediated disease. Arch Pathol Lab Med. 1989;113:772–6.
Souza D. A new no-touch preparation technique. Technical notes. Scand J Thorac Cardiovasc Surg. 1996;30:41–4.
Wan S, Shukla N, Angelini GD, Yim AP, Johnson JL, Jeremy JY. Nitric oxide-donating aspirin (NCX 4016) inhibits neointimal thickening in a pig model of saphenous vein-carotid artery interposition grafting: a comparison with aspirin and morpholinosydnonimine (SIN-1). J Thorac Cardiovasc Surg. 2007;134:1033–9.
Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294:2446–54.
Taggart DP, Ben Gal Y, Lees B, et al. A randomized trial of external stenting for saphenous vein grafts in coronary artery bypass grafting. Ann Thorac Surg. 2015;99:2039–45.
Dashwood MR, Tsui JC. ‘No-touch’ saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench. Vascul Pharmacol. 2013;58:240–50.
Tsui JC, Souza DS, Filbey D, Bomfim V, Dashwood MR. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a 'no-touch' technique. Br J Surg. 2001;88:1209–15.
Dreifaldt M, Souza DS, Loesch A, et al. The “no-touch” harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorum. J Thorac Cardiovasc Surg. 2011;141:145–50.
Fernández-Alfonso MS, Gil-Ortega M, Aranguez I, et al. Role of PVAT in coronary atherosclerosis and vein graft patency: friend or foe? Br J Pharmacol. 2017;174:3561–72.
Dashwood MR, Savage K, Tsui JC, et al. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. J Thorac Cardiovasc Surg. 2009;138:334–40.
Johansson BL, Souza DS, Bodin L, et al. Slower progression of atherosclerosis in vein grafts harvested with “no touch” technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. Eur J Cardiothorac Surg. 2010;38:414–9.
Johansson B, Samano N, Souza D, et al. The no-touch vein graft for coronary artery bypass surgery preserves the left ventricular ejection fraction at 16 year postoperatively: long-term data from a longitudinal randomised trial. Open Heart. 2015;2:e000204. https://doi.org/10.1136/openhrt-2014-000204.
Samano N, Geijer H, Lidén M, Fremes S, Bodin L, Souza D. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg. 2015;150:880–8.
Verma S, Lovren F, Pan Y, et al. Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. Eur J Cardiothorac Surg. 2014;45:717–25.
Hwang HY, Kim MA, Seo JW, Kim KB. Endothelial preservation of the minimally manipulated saphenous vein composite graft: histologic and immunohistochemical study. J Thorac Cardiovasc Surg. 2012;144:690–6.
Hwang HY, Kim JS, Kim KB. Angiographic equivalency of off-pump saphenous vein and arterial composite grafts at one year. Ann Thorac Surg. 2010;90:516–21.
Hwang HY, Kim JS, Oh SJ, Kim KB. A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: Early results. J Thorac Cardiovasc Surg. 2012;144:1027–33.
Kim KB, Hwang HY, Hahn S, Kim JS, Oh SJ. A randomized comparison of the Saphenous Vein Versus Right Internal Thoracic Artery as a Y-Composite Graft (SAVE RITA) trial: One-year angiographic results and mid-term clinical outcomes. J Thorac Cardiovasc Surg. 2014;148:901–8.
Hwang HY, Lee KH, Han JW, Kim KB. Equivalency of saphenous vein and arterial composite grafts: 5-year angiography and midterm clinical follow-up. Ann Thorac Surg. 2016;102:580–8.
Kim YH, Oh HC, Choi JW, Hwang HY, Kim KB. No-touch saphenous Vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg. 2017;103:1489–97.
Gaudino M, Alessandrini F, Pragliola C, et al. Composite Y internal thoracic artery-saphenous vein grafts: short-term angiographic results and vasoreactive profile. J Thorac Cardiovasc Surg. 2004;127:1139–44.
Glineur D, Boodhwani M, Poncelet A, et al. Comparison of fractional flow reserve of composite Y-grafts with saphenous vein or right internal thoracic arteries. J Thorac Cardiovasc Surg. 2010;140:639–45.
Hwang HY, Koo BK, Oh SJ, Kim KB. Morphologic changes of the saphenous vein Y-composite graft based on the left internal thoracic artery: 1-year intravascular ultrasound study. J Thorac Cardiovasc Surg. 2015;149:487–93.
Hwang HY, Koo BK, Yeom SY, Kim TK, Kim KB. Endothelial shear stress of the saphenous vein composite graft based on the internal thoracic artery. Ann Thorac Surg. 2018;105:564–71.
Parsonnet V, Lari AA, Shah IH. New stent for support of veins in arterial grafts. Arch Surg. 1963;87:696–702.
Ben-Gal Y, Taggart DP, Williams MR, et al. Expandable external support device to improve Saphenous Vein Graft Patency after CABG. J Cardiothorac Surg. 2013;8:122.
Murphy GJ, Newby AC, Jeremy JY, Baumbach A, Angelini GD. A randomized trial of an external Dacron sheath for the prevention of vein graft disease: The Extent study. J Thorac Cardiovasc Surg. 2007;134:504–5.
Rescigno G, Aratari C, Matteucci SM, et al. Saphenous vein graft wrapping by nitinol mesh: A word of caution. Thorac Cardiovasc Surg. 2015;63:292–7.
Meirson T, Orion E, Di Mario C, et al. Flow patterns in externally stented saphenous vein grafts and development of intimal hyperplasia. J Thorac Cardiovasc Surg. 2015;150:871–8.
Webb CM, Orion E, Taggart DP, Channon KM, Di Mario C. OCT imaging of aorto-coronary vein graft pathology modified by external stenting: 1-year post-surgery. Eur Heart J Cardiovasc Imaging. 2016;17:1290–5.
Taggart DP, Amin S, Djordjevic J, et al. A prospective study of external stenting of saphenous vein grafts to the right coronary artery: the VEST II study. Eur J Cardiothorac Surg. 2017;51:952–8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Prof. David Taggart states that he has received research funding, speaking, and traveling honoraria from Vascular Graft Solutions (VGS), and also has share options in VGS.
Ki-Bong Kim, Ho Young Hwang, and Domingos Souza state that they have no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Kim, KB., Hwang, H.Y., de Souza, D.S.R. et al. Saphenous vein: advances. Indian J Thorac Cardiovasc Surg 34 (Suppl 3), 251–257 (2018). https://doi.org/10.1007/s12055-018-0753-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-018-0753-9